Ironwood Pharmaceuticals

NASDAQ: IRWD
Developing and commercializing innovative medicines focused on gastrointestinal diseases.
Developing and commercializing innovative medicines focused on gastrointestinal diseases.

Investment Team

Sector

Life Sciences

Category

Therapeutics

Location

Cambridge, MA

Initial Investment

2002
Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ: IRWD) developed linaclotide, a first-in-class therapy that received FDA approval for both irritable bowel syndrome and chronic constipation.